Trials / Completed
CompletedNCT00002036
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-HIV Immune Serum Globulin (Human) |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2009-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00002036. Inclusion in this directory is not an endorsement.